Boehringer Ingelheim baut die Unternehmensleitung um
Boehringer Ingelheim - Wikipedia
Jean Scheftsik de Szolnok | CHEManager
Making More Health - Effective collaboration between the #business sector and civil society is key to addressing some of the world's most pressing challenges. Our partnership between Boehringer Ingelheim and Ashoka is
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
Boehringer Ingelheim chops 295 jobs in France but vows $380M in animal health investments | FiercePharma
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
Partnerships for One Health cannot wait | Boehringer Ingelheim
sustainably fighting rabies info hub | Boehringer Ingelheim
Jean Scheftsik de Szolnok (@Jean2S) / Twitter
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
Boehringer Ingelheim on Twitter: "¡Agéndalo! 🗓 El lunes 26 de octubre, Jean Scheftsik de Szolnok (@Jean2S) se presentará en el @WorldHealthSmt. Junto a líderes globales disertará sobre el potencial de #OneHealth para
Boehringer Ingelheim on Twitter: "Our #business demands close cooperations! Our current and incoming Head of #AnimalHealth @JoachimHasenma1 and Jean Scheftsik de Szolnok @Jean2S respectively toured our Taizhou site in #China to learn
Press Kit Animal Health | Boehringer Ingelheim
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
Interview with Jean Scheftsik de Szolnok, Boehringer Ingelheim
Boehringer pharma chief heads for the exit amid a top-level reshuffling | FiercePharma
Boehringer Ingelheim - Drug Discovery and Development
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
Boehringer Ingelheim beginnt mit dem Bau seines künftigen Produktionszentrums für Veterinärimpfstoffe – Acteurs du franco-allemand
COVID-19 at the Center for Global Health | TUM Fakultät für Medizin
Boehringer Ingelheim baut RCV weiter aus
Boehringer y Ashoka invitan a imaginar modelos de negocio innovadores en salud
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
Jean de Szolnok | Les Echos
